Evaluate Vantage 2020 Review: Biopharma IPOs and Venture Financing Break Records; Global Drug Stocks Add Half a Trillion Dollars in Market Capitalization
Evaluate Vantage Pharma, Biotech & Medtech 2020 in Review report, published today. Companies developing COVID-19 treatments experienced some of the largest gains; the greatest market cap increases by percentage were Novovax (2,702%) and South Korea’s Shin Poong (1,613%). 2020 also saw an unprecedented amount of cash flow into the sector. Drug developers raised a record-breaking $12.7 billion via IPO. This was more than twice the total raised in 2019, and the average amount raised ($167 million) nearly doubled. Private companies also broke records, with an astonishing $20bn invested by ventu...
Source: financialbuzz.com